Beryllium Research Symposium: Basic Mechanisms and Human Health
June 25- 26, 2002
National Library of Medicine, Bethesda, MD

 Contents

 Introduction

 Welcome

 Agenda

 Session 1

 Session 2

 Session 3

 Session 4

 Session 5

 Attendees

Invited Speakers

"Chemicals + immunologic lung disease: gene + environment"
Anthony Newman-Taylor
Imperial College School of Medicine
National Heart & Lung Institute

"Immunopathogenesis of sarcoidosis"
Gianpietro Semenzato, MD
Padua University School of Medicine

"Multidisciplinary research- the key to solving the beryllium disease
puzzle."
Kay Kreiss, MD
Division of Respiratory Disease Studies
National Institute for Occupational Safety and Health

"Physicochemical determinants of beryllium toxicity using in vitro
and in vivo models"
Gregory L. Finch, PhD
Pfizer Global Research & Development

"Effects and fate of ultrafine particles"
Günter Oberdörster, PhD
Environmental Medicine
University of Rochester

Gary Hunninghake
University of Iowa
"Second messenger pathways activated by endotoxin and other environmental exposures."

Panel discussion on the Ethical Legal and Social Implications of Beryllium Disease:

• Myron C. Harrison, MD
  Exxon Mobil Corp.
• Reed Durham
  Y12 Plant
• Susan L. Rose, Ph.D.
  Office of Biological and Environmental
  Research, Office of Science
  U.S. Department of Energy
• Jonathan D. Moreno, Ph.D.
  Center for Biomedical Ethics
  University of Virginia